Zacks Investment Research Upgrades Trupanion Inc (TRUP) to “Buy”
Trupanion Inc (NYSE:TRUP) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday. The brokerage currently has a $29.00 price target on the financial services provider’s stock. Zacks Investment Research‘s target price suggests a potential upside of 8.09% from the stock’s current price.
According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “
TRUP has been the topic of a number of other research reports. BidaskClub downgraded Trupanion from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. Canaccord Genuity raised their price target on shares of Trupanion from $28.00 to $29.00 and gave the stock a “buy” rating in a report on Wednesday, August 2nd. Cowen and Company restated an “outperform” rating and set a $28.00 price target (up from $19.00) on shares of Trupanion in a report on Wednesday, August 2nd. Stifel Nicolaus reaffirmed a “buy” rating and set a $24.00 price objective (up from $18.00) on shares of Trupanion in a research report on Wednesday, August 2nd. Finally, Royal Bank Of Canada boosted their price objective on shares of Trupanion from $19.00 to $26.00 and gave the company an “outperform” rating in a research report on Wednesday, August 2nd. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Trupanion has an average rating of “Buy” and an average price target of $26.50.
Trupanion (NYSE TRUP) traded up 4.58% during midday trading on Wednesday, reaching $28.06. 275,348 shares of the company were exchanged. Trupanion has a 52-week low of $13.71 and a 52-week high of $28.26. The firm’s 50-day moving average price is $23.17 and its 200 day moving average price is $20.14. The stock’s market capitalization is $841.66 million.
Trupanion (NYSE:TRUP) last announced its quarterly earnings data on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.01. Trupanion had a return on equity of 3.57% and a net margin of 0.71%. The firm had revenue of $58.30 million during the quarter, compared to the consensus estimate of $57.58 million. During the same period in the prior year, the business earned ($0.03) EPS. The business’s revenue for the quarter was up 27.3% on a year-over-year basis. Equities analysts predict that Trupanion will post ($0.09) earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/04/zacks-investment-research-upgrades-trupanion-inc-trup-to-buy.html.
In other news, insider Darryl Rawlings sold 3,500 shares of Trupanion stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $21.13, for a total transaction of $73,955.00. Following the completion of the sale, the insider now directly owns 1,449,505 shares in the company, valued at approximately $30,628,040.65. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Ian Moffat sold 8,552 shares of Trupanion stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $23.20, for a total value of $198,406.40. Following the sale, the chief operating officer now owns 8,552 shares of the company’s stock, valued at $198,406.40. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 50,552 shares of company stock worth $1,151,754.
Large investors have recently added to or reduced their stakes in the stock. Teachers Advisors LLC raised its position in Trupanion by 31.9% during the fourth quarter. Teachers Advisors LLC now owns 42,725 shares of the financial services provider’s stock valued at $663,000 after acquiring an additional 10,340 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Trupanion by 14.1% in the first quarter. Bank of New York Mellon Corp now owns 56,991 shares of the financial services provider’s stock valued at $811,000 after acquiring an additional 7,054 shares during the last quarter. American International Group Inc. lifted its stake in Trupanion by 7.1% in the first quarter. American International Group Inc. now owns 8,864 shares of the financial services provider’s stock valued at $126,000 after acquiring an additional 588 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Trupanion in the first quarter valued at approximately $194,000. Finally, Alliancebernstein L.P. lifted its stake in Trupanion by 1.2% in the first quarter. Alliancebernstein L.P. now owns 16,700 shares of the financial services provider’s stock valued at $237,000 after acquiring an additional 200 shares during the last quarter.
Trupanion Company Profile
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.